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Abstract
Objectives: This study aimed to evaluate the effectiveness of systematic assessment of asthma-like symptoms and
environmental tobacco smoke (ETS) exposure during regular preventive well-child visits between age 1 and 4 years by well-
child professionals.
Methods: Sixteen well-child centres in Rotterdam, the Netherlands, were randomised into 8 centres where the brief
assessment form regarding asthma-like symptoms and ETS exposure was used and 8 centres that applied usual care. 3596
and 4179 children (born between April 2002 and January 2006) and their parents visited the intervention and control
centres, respectively. At child’s age 6 years, physician-diagnosed asthma ever, wheezing, fractional exhaled nitric oxide
(FeNO), airway resistance (Rint), health-related quality of life (HRQOL) and ETS exposure at home ever were measured. Linear
mixed models were applied.
Results: No differences in asthma, wheezing, FeNO, Rint or HRQOL measurements between intervention and control group
were found using multilevel regression in an intention-to-treat analysis (p.0.05). Children of whom the parents were
interviewed by using the brief assessment form at the intervention well-child centres had a decreased risk on ETS exposure
at home ever, compared to children who visited the control well-child centres, in an explorative per-protocol analysis
(aOR= 0.71, 95% CI:0.59–0.87).
Conclusions: Systematic assessment and counselling of asthma-like symptoms and ETS exposure in early childhood by well-
child care professionals using a brief assessment form was not effective in reducing the prevalence of physician-diagnosed
asthma ever and wheezing, and did not improve FeNO, Rint or HRQOL at age 6 years. Our results hold some promise for
interviewing parents and using information leaflets at well-child centres to reduce ETS exposure at home in preschool
children.
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Introduction
Asthma is a highly prevalent chronic condition associated with
considerable morbidity, reduced health-related quality of life
(HRQOL) and significant costs for public health [1,2]. Interven-
tions aimed at preventing childhood asthma are being developed
and evaluated [3–9]. While the majority of asthma management
education for parents occurs in the clinical setting, increasingly,
multifaceted environmental interventions to decrease asthma-like
symptoms are delivered by community health workers [7].
Previous studies identified positive outcomes associated with
community health worker-delivered interventions, including
decreased asthma-like symptoms [7].
In the Netherlands, growth, development and health of all
children (0–19 years) is monitored in a nationwide program with
regular visits at set ages by well-child care physicians and nurses
[10]. The nationwide program is offered free of charge by the
government and participation is voluntary (attendance rate ca.
90%) [11]. The well-child care setting creates an opportunity for
tailored prevention and promotion of healthy child development.
During well-child visits, among other topics that are relevant at the
developmental stage of the child, the well-child professionals
(medical doctors and nurses) should pay attention to the presence
of asthma-like symptoms. However, until now, no systematic
assessment of the presence of asthma-like symptoms in early
childhood by well-child professionals has been applied at well-
child centres in the Netherlands. In the Netherlands, the
nationwide well-child care program advises to interview parents
regarding environmental tobacco smoke (ETS) exposure to
preschool children [11]. However, information leaflets with regard
to ETS exposure are not yet given routinely to parents of children
aged 1 to 4 years who are exposed to ETS.
This study aimed to evaluate the effectiveness of systematic
assessment of asthma-like symptoms and ETS exposure between
age 1 and 4 years by well-child professionals. We hypothesised that
systematic assessment of asthma-like symptoms and ETS exposure
to parents of preschool children (and subsequent counselling such
as providing information leaflets or arranging a referral when
needed) reduces the prevalence of physician-diagnosed asthma
ever and wheezing frequency, and improves fractional exhaled
nitric oxide (FeNO, a biomarker of airway inflammation), airway
resistance (Rint) and HRQOL measurements at age 6 years. In
addition to the study protocol [12], we evaluated whether this
approach resulted in a reduction of ETS exposure at home (‘ETS
exposure at home ever’ measured at child age 6 years).
Methods
Ethics Statement
This study is embedded in the Generation R Study, a
prospective population-based cohort [13], in collaboration with
the regional well-child care organisation Centre for Youth and
Family in Rotterdam. The Generation R Study was conducted in
accordance with the guidelines proposed in the Declaration of
Helsinki, and was approved by the Medical Ethical Committee of
the Erasmus Medical Centre. All parents who participated in the
Generation R Study provided written informed consent for the use
of data regarding their child for research aimed at identifying
factors influencing the health of young children. In this study, to
evaluate the brief assessment form regarding asthma-like symp-
toms and ETS exposure applied by well-child professionals, we
used data that were collected in the Generation R Study. We are
prepared to make the data available upon request.
Study Design
Details of our study design were published previously (see File
S1) [12]. This study started in June 2005 and follow-up at age 6
years was completed in January 2012. In total, 7775 children (born
between April 2002 and January 2006) entered the study (Fig. 1).
Sixteen well-child centres that participated in the data collection of
the Generation R Study were randomized into 8 well-child centres
that applied the brief assessment form regarding asthma-like
symptoms and ETS exposure at each regularly scheduled visit to
the well-child centre between age 1 and 4 years, and 8 centres that
applied usual care. First, the well-child centres were ranked (by
researcher ADM) based on the socioeconomic status of their
neighbourhood. Well-child centres in each subsequent couple in
this list were randomly assigned to the intervention group (n= 8)
or the control group (n= 8). Parents were not aware of the
research condition they were allocated to. The protocol for this
trial and supporting CONSORT checklist are available as
supporting information; see Checklist S1 and Protocol S1.
Intervention and Usual Care
When parent and child attended the well-child centre allocated
to the intervention group, the professionals used a brief assessment
form regarding asthma-like symptoms and ETS exposure during
the regular visits at age 14, 24, 36 and 45 months. Details of this
form were published previously [12]. In summary, with regard to
asthma-like symptoms the brief form included items on wheezing,
and shortness of breath or dyspnea. Furthermore, the form
included an item that assessed whether the child had been exposed
to ETS during the past year (no, yes-sometimes, yes-on a regular
basis, yes-often or daily, unknown).
When parents reported that their child had at least 3 episodes of
any asthma-like symptoms during the past 12 months and at least
1 episode of asthma-like symptoms in the past 4 weeks, the well-
child professionals could provide them with a leaflet with
information about asthma. If the child had been free of asthma-
like symptoms during the past 4 weeks, the well-child professionals
could advise a visit to the general practitioner should the child’s
asthma-like symptoms return. When parents reported that their
child had at least 3 episodes of asthma-like symptoms during the
past 12 months, of which at least 1 in the past 4 weeks, and the
child had not yet been treated by the general practitioner or
paediatrician in the past 4 weeks, the well-child professionals could
refer to the asthma nurse and/or general practitioner. If the child
had already been treated by the general practitioner or
paediatrician in the past 4 weeks, the well-child professionals
could refer to the asthma nurse.
If the child had been exposed to ETS (sometimes, on a regular
basis, often or daily), the well-child professional could discuss
health risks of ETS exposure to preschool children (health risks),
and discuss whether parents could be motivated and prepared to
stop ETS exposure to their child (house rules) and provide them
with an information leaflet about preventing their child from
exposure to ETS. The well-child professionals from the interven-
tion centres were informed during a two-hour session about the
intervention.
The control centres applied current routine practice, addressing
the presence of general health symptoms during the regular well-
child visits and ETS exposure (at least at age 18 months) [11].
However, no specific, systematic assessment of the presence of
asthma-like symptoms and ETS exposure by the use of a brief
form was performed by the well-child professionals in the control
group.
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Primary and Secondary Outcomes
Data from parents were collected in the Generation R Study by
postal questionnaires at enrolment, and at the first, 2nd, 3rd, 4th
and 6th year of life. Response rates for these questionnaires were
71%, 76%, 72%, 73% and 68%, respectively. The primary
outcome measure was physician-diagnosed asthma ever, obtained
by a parent-reported questionnaire at age 6 years.
Secondary outcomes were current wheezing frequency (as
reported by parents), FeNO, Rint and HRQOL as reported by
parents. Reducing ETS exposure to preschool children was one of
the objectives of counselling following systematic assessment of
ETS. Therefore, in addition to the proposed outcomes [12], we
evaluated at age 6 years whether the intervention had reduced
ETS exposure at home ever (as reported by parents).
Wheezing frequency (never, 1–3 episodes, $4 episodes) in the
past 12 months was assessed using a parent-reported question from
the International Study of Asthma and Allergies in Childhood
(ISAAC) [14].
FeNO was measured according to American Thoracic Society
guidelines [15] at age 6 years at the research centre (NIOX
chemiluminescence analyser, Aerocrine AB, Solna, Sweden).
Statistical analyses were additionally adjusted for technique to
take into account computer-calculated and researcher-observed
FeNO values. FeNO was normalized by elog transformation.
At age 6 years, Rint (Micro Rint, MicroMedical, Rochester,
Kent, UK) was measured at the research centre during tidal
breathing, with occlusion of the airway at tidal peak expiratory
flow. Median values for at least 5 acceptable Rint measurements
were calculated and used to calculate Z-scores, additionally
adjusted for median variation of the study period [16,17].
The CHQ-PF28 in the parent-reported questionnaire was used
to measure HRQOL of the child at age 6 years [18]. Based on 28
items, the CHQ-PF28 measures the HRQOL of children and
their families across 13 scales [19,20]. The following eight multi-
item scales measure the child’s HRQOL: Physical functioning, Role
functioning: emotional, Role functioning: physical, Bodily pain, General
behaviour, Mental health, Self-esteem, General health perceptions. These
multi-item scales were summarised into a Physical summary measure
and a Psychosocial summary measure. Furthermore we used the Change
in health item. The impact of the child’s health on the caregiver’s
Figure 1. Flow of participants through the study. FeNO= fractional exhaled nitric oxide, HRQOL=health related quality of life, Rint = airway
resistance, ETS = environmental tobacco smoke.
doi:10.1371/journal.pone.0090982.g001
Evaluation of Assessment of Asthma-Like Symptoms
PLOS ONE | www.plosone.org 3 March 2014 | Volume 9 | Issue 3 | e90982
and family’s HRQOL was measured across the remaining four
multi-item scales: Parental impact: emotional, Parental impact: time,
Family cohesion and Family activities. All scale measures were
transformed to scores ranging from 0 to 100. Lower scores
correspond to lower HRQOL. Summary measures were stan-
dardised with a mean of 50 and standard deviation of 10 to reflect
general US population norms for children [19,20].
The outcome ‘ETS exposure at home ever (yes, no)’ at age 6
years was defined and based on parent-reported questionnaires at
age 2, 3 and 6 years, using the question: ‘Do people smoke
occasionally at home? (yes, no)’. ‘ETS exposure at home ever’ at
age 6 years was scored ‘yes’ if there was ETS exposure at home at
age 2 or 3 or 6 years.
Covariates
We used information collected in the Generation R Study on
maternal characteristics (educational level, net household income,
ethnicity, single motherhood and history of asthma or atopy) for
the intervention and control group. Information about the highest
attained maternal educational level (low, moderate, high),
maternal ethnicity (Dutch, other western, non-western) and single
motherhood (yes, no) and maternal history of asthma or atopy (yes,
no) were obtained at enrolment by questionnaires. Maternal
educational level and maternal ethnicity were defined according to
the classification of Statistics Netherlands [21,22]. Data on
household income (,J1600/month, $J1600/month) was ob-
tained at the child’s age of 3 years, using the 2005 monthly general
labour income as the cut-off point [23]. Information on child’s
gender (boy, girl), gestational age at birth (weeks) and birth weight
(grams), were obtained from medical records. We used informa-
tion collected in the Generation R Study on child’s characteristics
that were established using parent-reported questionnaires which
included: ETS exposure at home (yes, no) (reported during
pregnancy) [24]; breastfeeding ever at age 0–6 months (yes, no);
keeping pets (yes, no) at the 1st year of life; respiratory tract
infections (yes, no) and wheezing (yes, no) at the 1st year of life.
Statistical Analyses
Baseline data for the intervention and control group were
described using descriptive statistics, which were tested for
differences using multinomial regression adjusted for randomisa-
tion stratum (cluster). All participants were analysed according to
the ‘‘intention-to-treat’’ principle.
The prevalence of ETS exposure at home before (fetal life to age
6 months), during (at age 14–45 months) and after (at age 6 years)
the study period was described. P values for differences in the
prevalence of ‘ETS exposure at home’ between intervention and
control group were calculated by means of the Chi-square test.
Although not according to the study protocol, several children
participating in the control group also visited the intervention
centres and assessment of asthma-like symptoms and ETS
exposure by a brief form was applied to a part of the parents of
these children. Contamination of intervention and control
condition may possibly also have occurred by moving to another
neighbourhood in the city and visiting another well-child centre.
Because this contamination may have reduced the differences in
results between intervention and control group, we amended the
study protocol [12] and in addition to the intention-to-treat
analyses we performed a per-protocol analysis. In the per-protocol
analysis we included children who were allocated to the
intervention group and also received the allocated intervention
(n = 2718). In the control group only children were included when
they were allocated to the control group and received usual care
(n = 3497) (see Fig. 1). Outcomes at age 6 years were predicted
with a model using two predictors: research condition (interven-
tion or usual care) and baseline value of the outcome variable
[25,26].
To prevent bias associated with attrition, missing data at
baseline and missing outcomes were multiple imputed (10 imputed
datasets) on the basis of the correlation between each variable with
missing values and other parental and child characteristics [27] to
reduce bias and improve efficiency [28]. Regression analyses were
performed in the original data and after the multiple imputation
procedure. Since we found similar effect estimates (with and
without multiple imputation) the final results in our paper are
presented as effect estimates with its 95% Confidence Intervals
(95%CI) with adjustment for randomisation stratum, derived from
the original (unimputed) data. Multilevel regression analyses were
applied to allow for dependency between the individual measure-
ments within the 16 randomised well-child centres. (the GEN-
LINMIXED procedure in SPSS and PROC GLIMMIX proce-
dure in SAS) [29,30]. We considered two levels: the cluster level
(well-child center) and the individual(child) level. In the final
model, we used the default covariance structure in the multilevel
regression analysis in SPSS. The difference between intervention
and control group on the categorical outcomes ‘physician-
diagnosed asthma ever (yes/no)’ and ‘ETS exposure at home
(yes/no)’ were studied using the ‘binomial’ distribution and
link = logit. The difference between intervention and control
group on the categorical outcome ‘Wheezing frequency (never, 1–
3 times/year, .3 times/year)’ was studied using the ‘multinomial’
distribution and link = logit. The differences between intervention
and control group on the health-related quality of life scales were
studied using the ‘poisson’ distribution and link = log. The
differences between intervention and control group on the
outcomes FeNO and Rint were studied using the ‘normal’
distribution and link = identity. FeNO was normalized by elog
transformation.
Potential effect modification of socio-demographic characteris-
tics and baseline values of the outcomes on the association between
the research condition (intervention or care as usual group) and
the outcomes was explored. First, we fit a multinomial regression
model with randomisation stratum and baseline values of the
outcome. Second, we added socio-demographic characteristics
(child’s gender and maternal ethnic background and educational
level) and baseline values of the outcomes as an interaction
separately [12,31,32]. The interaction terms were evaluated at p,
0.10 level [33].
Random treatment allocation ensures that intervention status
will not be confounded with either measured or unmeasured
baseline characteristics [34]. Therefore, the effect of the interven-
tion on outcomes was estimated by comparing outcomes between
the intervention and control group, only adjusted for randomisa-
tion stratum and baseline prevalence of the outcomes.
It should be considered that given multiple comparisons, there is
an 1-in-20 chance of a false association for each comparison (Type
I error at p = 0.05) [35]. Bonferroni correction was applied to
correct for multiple testing (P= 0.05/number of comparisons)
[35].
In addition, a process evaluation of the intervention was
performed. The study is reported according to the CONSORT
standards for reporting RCTs [30,36]. Analyses were performed
using the Statistical Package for Social Sciences (SPSS) version
20.0 for Windows (SPSS Inc, Chicago, IL, USA) and SAS 9.2
(SAS Institute, Cary, NC, USA).
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Results
Recruitment
There were 8 intervention and 8 control well-child centres,
involving 3596 and 4179 children (and their parents) visiting these
well-child centres, respectively. The different rates of participation
of the children in the different elements of the study are shown in
the flow diagram (Fig. 1).
Table 1 summarizes the baseline characteristics of the study
population, stratified by intervention and control group. At
baseline, no differences were found between the characteristics
of the intervention and control group, after adjustment for
randomisation stratum (p.0.05).
Asthma (Related) Outcomes
At age 6 years, multilevel regression analysis indicated no
differences in asthma, wheezing frequency, FeNO or Rint
measurements between the intervention and control group (p.
0.05) (Table 2 and 3).
HRQOL
The response rate regarding the CHQ-PF28 scales at age 6
years was different for each scale and varied between 57–59%
(n= 4410–4590). Baseline measurements were available for 8 out
of 13 CHQ-PF28 scales. At age 6 years, no differences in HRQOL
were found between the intervention and control group, after
adjustment for baseline HRQOL and randomisation stratum (p.
0.05) (Table 2 and 3).
Table 1. Baseline characteristics by allocation group (n = 7775).
Total Intervention Care as usual P value*
Missing
N=7775 16
clusters
n=3596 (46.3%) 8
clusters
n =4179 (53.7%) 8
clusters
Maternal characteristics
Educational level 732 (9.4)
Low 1610 (22.9) 717 (21.8) 893 (23.8) 0.96
Middle 2081 (29.5) 954 (29.0) 1127 (30.0)
High 3352 (47.6) 1617 (49.2) 1735 (46.2)
Net household income 2101 (27.0)
,1600 J/month 1536 (27.1) 608 (23.6) 928 (29.9) 0.56
$1600 J/month 4138 (72.9) 1966 (76.4) 2172 (70.1)
Ethnicity 736 (9.5)
Dutch 3817 (54.2) 1884 (57.4) 1933 (51.5) 0.48
Other western 1186 (16.8) 498 (15.2) 688 (18.3)
Non-western 2036 (28.9) 900 (27.4) 1136 (30.2)
Single motherhood (yes) 892 (11.5) 865 (12.6) 408 (12.7) 457 (12.4) 0.93
Smoking during pregnancy (yes) 1717 (22.1) 1510 (24.9) 679 (24.5) 831 (25.3) 0.40
History of asthma or atopy (yes) 1608 (20.7) 2402 (38.9) 1140 (39.1) 1262 (38.8) 0.80
Child’s characteristics
Gender (male) 0 (0) 3920 (50.4) 1796 (49.9) 2124 (50.8) 0.44
Gestational age at birth 0 (0)
,37 weeks 472 (6.1) 208 (5.8) 264 (6.3) 0.35
$37 weeks 7303 (93.9) 3388 (94.2) 3915 (93.7)
Birth weight (grams) 0 (0)
,2500 grams 438 (5.6) 189 (5.3) 249 (6.0) 0.24
$2500 grams 7337 (94.4) 3407 (94.7) 3930 (94.0)
Breastfeeding ever (yes) 1830 (23.5) 6143 (91.9) 2819 (90.6) 3324 (92.9) 0.22
Keeping pets (yes) 2198 (28.3) 1850 (33.2) 872 (33.2) 978 (33.1) 0.66
ETS exposure at home (yes) 3542 (45.6) 662 (15.6) 313 (15.4) 349 (15.8) 0.99
Respiratory tract infections (yes) 2632 (33.9) 3230 (62.8) 1512 (62.8) 1718 (62.8) 0.84
Wheezing (yes) 2860 (36.8) 1482 (30.2) 691 (30.0) 791 (30.3) 0.83
Values are absolute numbers (percentages) for categorical variables. *Tested for differences in characteristics in intervention and control group using multinomial
regression adjusted for randomisation stratum. Characteristics established using postal questionnaires during pregnancy included: smoking during pregnancy (yes, no),
maternal atopy (yes, no), maternal ethnicity (Dutch, non-Western, other-Western) and maternal educational level. The Dutch Standard Classification of Education was
used to categorise women’s self-reported highest education qualification [21]: low (less than 4 years of high school), middle (college), and high (Bachelor’s degree,
Master’s degree). Data on net household income were available at the 2nd year of life. Birth weight (grams) and gestational age at birth (weeks) were obtained from
medical records. Postnatal factors were established using questionnaires and included: breastfeeding ever at age 0–6 months (yes, no); keeping pets (yes, no) at the 1st
year of life; ETS exposure at home (yes, no) measured at age 0–6 months; respiratory tract infections (yes, no) and wheezing (yes, no) at the 1st year of life.
doi:10.1371/journal.pone.0090982.t001
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ETS Exposure: Baseline to Follow-up
Figure 2 shows the prevalence of ETS exposure at home before
(fetal life to age 6 months), during (at age 14–45 months) and after
(at age 6 years) the study period (according to the intention-to-treat
analysis). During fetal life and at age 6 months, the prevalence of
ETS exposure at home was around 16% in both the intervention
and control group (p.0.05). At age 2 years, ETS exposure at
home to children participating in the intervention group remained
similar, but increased to 19% in the control group. At age 2, 3 and
6 years, the prevalence of ETS exposure at home was higher in
children participating in the control group (age 2 years: p = 0.02,
age 3 years: p = 0.004, age 6 years: p.0.05).
No differences in ETS exposure at home at age 2 and 3 years
were found between intervention and control group after
adjustment for baseline ETS exposure at home (reported during
fetal life) using multinomial regression in an intention-to-treat
analysis, (adjusted Odds Ratio [aOR]= 0.90, 95% Confidence
Interval [CI]:0.74–1.08 at age 2 years and aOR=0.81, 95%
CI:0.66–1.01 at age 3 years). However, in the per-protocol analysis
(n = 1560), multinomial regression analysis indicated a decreased
risk on ETS exposure at home in the intervention group at age 2
and 3 years (aOR=0.78, 95% CI:0.63–0.96 at age 2 years and
aOR=0.73, 95% CI:0.57–0.93 at age 3 years).
ETS Exposure: Outcome
At age 6 years, no differences between intervention and control
group were found on the outcome ‘ETS exposure at home ever’
using multilevel regression in an intention-to-treat analysis
including adjustment for baseline ETS exposure at home (reported
during fetal life) (aOR=0.82, 95% CI:0.66–1.03) (Table 2).
However, in an explorative per-protocol analysis, children who
received the intervention at the intervention well-child centres had
a decreased risk on ‘ETS exposure at home ever’ compared to
children who visited the control well-child centres and who did not
receive the intervention (aOR=0.71, 95%CI:0.59–0.87) (Table 3).
Table 2. Intention-to-treat analyses: Prevalence and effect estimates of primary and secondary outcomes at age 6 years follow-up
by allocation group.
Intervention n=3596 Care as usual n =4179
Adjusted effect estimates
[95% CI]*
Primary outcome at age 6 years
Physician-diagnosed asthma evera 86/2143 (4.0) 101/2425 (4.2) 1.01 (0.76–1.35)
Secondary outcomes at age 6 years
Wheezing frequencya
Never 1958/2143 (91.4) 2215/2425 (91.3) Reference
1–3 times/year 143/2143 (6.7) 157/2425 (6.5) 1.02 (0.79,1.31)
.3 times/year 42/2143 (2.0) 53/2425 (2.2) 0.99 (0.71,1.37)
Health-related quality of life (CHQ-PF28 scales)b
Physical functioning 97.30611.16 97.22611.17 0.00 (20.01,0.01)
Role functioning: emotional/behaviour 97.40610.78 97.59610.28 0.00 (20.01,0.00)
Role functioning: physicald 97.34611.41 97.34611.64 0.00 (20.01,0.01)
Bodily pain 86.46616.71 85.96617.47 0.01 (20.01,0.02)
General behaviourd 70.72615.20 71.44614.68 0.00 (20.02,0.03)
Mental healthd 81.65614.53 81.90614.43 0.00 (20.02,0.02)
Self esteemd 83.81615.31 83.35615.28 0.01 (20.01,0.03)
General health perceptions 87.19615.82 86.78615.74 0.00 (20.02,0.02)
Parental impact: emotional 88.76614.89 89.06614.52 20.01 (20.02,0.01)
Parental impact: time 95.83611.89 95.36613.12 0.00 (20.01,0.01)
Family activities 90.81616.34 90.50616.23 0.00 (20.01,0.01)
Family cohesion 76.31618.99 76.25617.94 0.00 (20.03,0.02)
Change in healthd 56.15615.46 56.84616.28 20.01 (20.06,0.04)
Physical summary scored 57.3666.22 57.1966.29 0.17 (20.58,0.93)
Psychosocial summary scored 53.0366.79 53.0866.66 20.08 (0.53,0.37)
FeNOc,d 7.20 (0.10–101.00) 7.30 (0.10–119.00) 20.01 (20.06,0.03)
Rintc,d 0.93 (0.13–2.43) 0.93 (0.19–2.32) 0.09 (20.17,0.35)
ETS exposure at homea 567/2840 (20.0) 745/3269 (22.8) 0.82 (0.66,1.03)
aData are numerator/denominator (%).
bMean 6 standard deviation.
cMedian (range).
dNo baseline measurement available. Numbers of children does not equal the sum of the denominators in each subgroup because only those with baseline and follow-
up data are included. Measurements on FeNO and Rint were available for respectively 3497 (45%) and 3828 (49%) of the participating children. FeNO= Fractional
exhaled Nitric Oxide, Rint = airway resistance, ETS = Environmental Tobacco Smoke. *Adjusted for randomisation stratum, and baseline prevalence of outcomes. Care as
usual is the reference group.
doi:10.1371/journal.pone.0090982.t002
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Interactions
No interaction effects on the outcomes were found of the
research condition (intervention or control group) with socio-
demographic characteristics or baseline values of the outcomes
(p.0.10) (data not shown). We found no effect of the frequency of
the intervention on outcomes.
Process Evaluation of the Intervention
In total, professionals at well-child centres completed 6826
forms to assess asthma-like symptoms and ETS exposure for 2718
children (75.6% of the 3596 children) participating in the
intervention group; and 1566 forms were completed for 682
children (16.3% of the 4179 children) participating in the control
group (see discussion). In half of the children participating in the
intervention group, the brief assessment form was applied at age
14 months (online repository Table S1). In total, the brief
assessment form was never applied to 25% of the children
participating in the intervention group. To 12% of the children
participating in the intervention group, the brief assessment form
was applied at each regularly scheduled visit up to year 4 (online
repository Table S2).
Of the children in the intervention group who had $3 episodes
of asthma-like symptoms in the past year, based on the data of the
assessment forms, 53% (162/308) was already treated by general
practitioner or paediatrician. Of the children with $3 episodes of
asthma-like symptoms in the past year and asthma-like symptoms
during the past month, 86% (119/139) was already treated by
general practitioner or paediatrician.
Using the assessment forms, well-child professionals in the
intervention group reported a decreasing prevalence of ETS
exposure to children participating in the intervention group with
increasing child’s age: 19% (276/1447) at the age of 14 months,
Table 3. Per-protocol analyses: Prevalence and effect estimates of primary and secondary outcomes at age 6 years follow-up by
allocation group.
Intervention n=2718 Care as usual n =3497
Adjusted effect estimates
[95% CI]*
Primary outcome at age 6 years
Physician-diagnosed asthma evera 69/1704 (4.0) 87/1987 (4.4) 0.98 (0.72,1.34)
Secondary outcomes at age 6 years
Wheezing frequencya
Never 1565/1704 (91.8) 1808/1987 (91.0) Reference
1–3 times/year 107/1704 (6.3) 134/1987 (6.7) 0.96 (0.73,1.28)
.3 times/year 32/1704 (1.9) 45/1987 (2.3) 0.96 (0.67,1.38)
Health-related quality of life (CHQ-PF28 scales)b
Physical functioning 97.48610.54 97.21610.97 0.00 (20.01,0.01)
Role functioning: emotional/behaviour 97.52610.70 97.64610.06 0.00 (20.01,0.00)
Role functioning: physicald 97.52610.99 97.20612.03 0.00 (20.01,0.01)
Bodily pain 86.46616.78 85.75617.62 0.01 (20.01,0.02)
General behaviourd 70.89615.22 71.61614.66 0.00 (20.02,0.03)
Mental healthd 81.72614.50 81.91614.43 0.01 (20.02,0.03)
Self esteemd 83.90615.32 83.26615.16 0.01 (20.01,0.03)
General health perceptions 87.64615.05 86.58615.82 0.00 (20.02,0.03)
Parental impact: emotional 89.07614.70 89.00614.60 0.00 (20.02,0.02)
Parental impact: time 95.97611.77 95.20613.50 0.00 (20.01,0.01)
Family activities 91.01616.05 90.60616.04 0.00 (20.01,0.01)
Family cohesion 76.52618.74 76.25617.90 0.00 (20.03,0.03)
Change in healthd 56.06615.20 57.10616.45 20.02 (20.07,0.03)
Physical summary scored 57.4965.87 57.1166.34 0.36 (20.37,1.10)
Psychosocial summary scored 53.0866.78 53.0966.61 20.07 (0.63,0.50)
FeNOc,d 7.30 (0.10–78.60) 7.40 (0.10–119.00) 20.01 (20.06,0.03)
Rintc,d 0.93 (0.13–2.43) 0.93 (0.19–2.32) 20.01 (20.30,0.28)
ETS exposure at homea 417/2226 (18.7) 642/2704 (23.7) 0.71 (0.59,0.87)e
*Adjusted for randomisation stratum, and baseline prevalence of outcomes. Care as usual is the reference group.
aData are numerator/denominator (%).
bMean 6 standard deviation.
cMedian (range).
dNo baseline measurement available.
eApplying Bonferroni correction: we performed 20 comparisons. At p = 0.0025 (i.e. 0.05/20), the decreased risk on ETS exposure at home ever in the intervention group
remained statistically significant.
Numbers of children does not equal the sum of the denominators in each subgroup because only those with baseline and follow-up data are included. Measurements
on FeNO and Rint were available for respectively 3497 (45%) and 3828 (49%) of the participating children. FeNO=Fractional exhaled Nitric Oxide, Rint = airway
resistance, ETS = Environmental Tobacco Smoke.
doi:10.1371/journal.pone.0090982.t003
Evaluation of Assessment of Asthma-Like Symptoms
PLOS ONE | www.plosone.org 7 March 2014 | Volume 9 | Issue 3 | e90982
16% (266/1627) at age 24 months, 17% (301/1767) at age 36
months and 13% (225/1760) at age 45 months. At age 14 months,
89% (245/276) of the children with ETS exposure received the
information leaflet regarding the prevention of ETS exposure.
However, after the first year, the information leaflet regarding
prevention of ETS exposure was less often provided to the parents
of children who were exposed to ETS: 61% (163/266) at age 24
months, 64% (192/301) at age 36 months and 53% (119/225) at
age 45 months.
Discussion
Systematic assessment of asthma-like symptoms and ETS
exposure by professionals at well-child centres, followed by
counselling (when indicated - including referral to asthma nurse/
general practitioner and providing parents with information
leaflets on avoiding ETS exposure) did not lead to a lower
prevalence of physician-diagnosed asthma ever, reduction in
parent-reported wheezing symptoms and did not improve FeNO,
Rint or parent-reported HRQOL at age 6 years. A decreased risk
on ETS exposure at home in the intervention group was found at
age 2 and 3 years, but at age 6 years no difference between
intervention and control group was found. Process evaluation
results showed that most children with wheezing were already
treated by their general practitioner or by a paediatrician. Further,
half of the parents of children with ETS exposure participating in
the intervention group did not receive the information leaflets on
ETS exposure at the intervention centres at age 45 months.
This is a community health worker-delivered intervention study
using physician-diagnosed asthma ever, wheezing frequency,
FeNO, Rint, HRQOL and (in addition) ETS exposure at home
ever at age 6 years as outcomes. In contrast to the positive
outcomes associated with community health worker-delivered
interventions (including decreased asthma-like symptoms) reported
by Postma et al [7], our study did not show a lower prevalence of
asthma or wheezing after follow-up until age 6 years. Maybe more
intensive counselling or interventions based on social cognitive
theory, are required to achieve an effect on the asthma related
outcomes. By using FeNO and Rint as outcomes we could
evaluate the effect of the intervention on airway inflammation and
lung function at age 6 years [37,38], but no effect could be
demonstrated. No differences in parent-reported HRQOL were
found between intervention and control group, which possibly can
be explained by the fact that the intervention did not reduce
wheezing.
In addition to the review by Priest et al [39], showing that
intensive and repeated counselling interventions seem to be
promising to reduce ETS exposure, we found a transient effect
of brief counselling aimed to avoid ETS exposure in children at
preschool age. To increase efficiency of well-child visits, low
Figure 2. Prevalence of ETS exposure at home of intervention and control (usual care) group by child’s age (Intention-to-treat
analysis). ETS exposure at home was defined based on the question ‘Do people smoke occasionally at home?’. Values are percentages and were
tested for differences in characteristics in intervention and control group using logistic regression analyses. Population for analysis (N) and P values:
Prenatal (N = 5598): p.0.05, 6 months (N= 4233): p.0.05, age 2 years (N = 5290): p = 0.02, age 3 years (N = 4894): p = 0.004, age 6 years (N = 4604): p.
0.05.
doi:10.1371/journal.pone.0090982.g002
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intensive and brief assessments and health promotion interventions
are preferred. However, process evaluation results showed that
half of the parents of children with ETS exposure did not receive
the information leaflet regarding prevention of ETS exposure at
age 45 months. Apparently, for unknown reason, once prevention
of ETS exposure was applied at the first year of life, professionals
at well-child care did not tend to repeat the intervention later on
while repeated feedback seems to be most effective to reduce the
proportion of parents quitting smoking [40,41].
The strengths of this study include the integration in current
practice with a brief assessment form regarding asthma-like
symptoms and ETS exposure, the large number of parents
participating, the longitudinal design (with follow-up until child
age 6 years) and large number of FeNO and Rint measurements.
Limitations include shortcomings in the application of the brief
assessment forms and counselling. Possible reasons are falling
attendance of parents to the well-child centre; lack of time or
priority is given to other health questions during the well-child visit
or professionals who are not familiar with the intervention, that is
still not routine practice. In this study, the professionals were
provided with a two-hour specific training on how to apply and
use the brief assessment form regarding asthma-like symptoms and
ETS exposure. This level of instruction may not be optimal as we
did not organize refreshment sessions nor provided feedback on
performance or assessed its effect [42].
The study faced some difficulties. In contrast to what was
described in our study protocol [12], data on inhaled steroids
prescribed by a physician was not available at age 6 years. Asthma
at age 6 years was defined as physician-diagnosed asthma ever,
obtained by a parent reported questionnaire. In the future, at
child’s age 10 years, data on inhaled steroids will be available and
we recommend repeating the analyses at age 10 years.
In addition to the proposed outcomes, we evaluated whether the
intervention had reduced ETS exposure at home. Children
participating in the control group also visited the intervention
well-child centres and systematic assessment and (when indicated)
counselling of asthma-like symptoms and ETS exposure was
applied to the parents of these children. Contamination of
intervention and control condition may possibly have occurred
by moving to another neighbourhood in the city and visiting
another well-child centre. Because this contamination may have
reduced the differences in results between intervention and control
group, we amended the study protocol and in addition to the
intention-to-treat analysis we performed a per-protocol analysis.
The following limitations would be a possible explanation for
the negative study results: the study included a relatively low-
intensity counselling intervention. However, the systematic assess-
ment of the presence of asthma-like symptoms in early childhood
by well-child professionals was prioritized and was considered
feasible and essential in the Dutch youth healthcare system [43].
Another explanation for the negative study results is that there
may have been a lack of intervention by the well-child care
professional, and also by the parents/children (to only 12% of the
children participating in the intervention group, the brief
assessment form was applied at each regularly scheduled visit up
to year 4 (Table S2)). Finally, since we used parent reports
regarding the presence of asthma symptoms, HRQOL and ETS
exposure at home, we may have lost precision.
We consider selection bias unlikely because a multiple imputed
analysis including all eligible children did not change the results.
Information bias should be considered for different measurements.
Although the validity of assessing ETS exposure by questionnaires
in epidemiological studies has been shown, misclassification may
occur due to underreporting [44]. However, the use of biomarkers
of tobacco smoke exposure in urine, saliva or blood, or nicotine in
indoor air seems not superior to self-report [44–47]. We have to
take into account the impact of parental symptom perception and,
possibly, misclassification in their reports on asthma diagnosis and
symptoms. Parental reports of wheezing are widely accepted in
epidemiological studies and reliably reflects the incidence of
wheezing in preschool children [14]. However, some misclassifi-
cation cannot be excluded [48].
The decreased risk on ‘ETS exposure at home ever’ in the
intervention group remained statistically significant even after
correction for multiple testing.
This study raises questions about whether it is feasible to prevent
the development of asthma by using systematic assessment and
counselling of asthma-like symptoms and ETS exposure by using
brief forms at well-child centres. We recommend further studies to
evaluate whether professionals at well-child centres can contribute
to optimal asthma management in other ways, and efforts are
needed to optimize the protocols that can be implemented in this
setting.
We also recommend further studies to improve the current
intervention to optimise asthma management at well-child care.
Based on previous results, it is recommended that professionals at
well-child centres encourage breastfeeding and advise parents of
children at high-risk of developing asthma to avoid ETS and
indoor allergens exposure to their children to reduce the
prevalence of asthma [3,49]. To optimise asthma management
and realise uniformity of practice at well-child care, future
opportunities are the development of an assessment to estimate
the risk of developing asthma at school age [50]. Further, we stress
the importance to ban smoking in public places and residential
settings to reduce children’s exposure to tobacco smoke.
Our study was embedded within the Dutch system of preventive
health care provided by well-child centres in Rotterdam, the
Netherlands. This may have consequences for the generalisability
of our results in other areas and countries and therefore evaluation
of our study in other, varied populations is recommended.
Conclusion
A systematic assessment of asthma-like symptoms and ETS
exposure by using brief assessment forms at well-child centres was
not effective in reducing the prevalence of physician-diagnosed
asthma ever and wheezing, and did not improve FeNO, Rint or
HRQOL at age 6 years. Our results hold promise for interviewing
parents and using information leaflets at well-child centres to
reduce ETS exposure at home in preschool children.
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